Biogen at TD Cowen Conference: Strategic Expansion and Challenges

Entity Intersection Graph

No entity connections available yet for this article.

}

Original Source

              On Monday, 02 March 2026, Biogen Inc. (NASDAQ:BIIB) showcased its strategic vision at the TD Cowen 46th Annual Health Care Conference. CEO Christopher Viehbacher detailed Biogen’s transformation, focusing on new product growth and pipeline expansion amid anticipated revenue declines due to legacy product competition. The company aims to drive future growth through strategic acquisitions and innovative launches, despite facing complex challenges in product rollouts.
            

Read full article at source